Abstract
Immunofluorescence of the postsynaptic marker proteins PSD-95 is notoriously difficult using conventional antibodies. We describe new reagents based on a small single-domain antibody that allows highly sensitive detection of PSD-95 without special sample treatment.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Coley AA, Gao WJ (2018) PSD95: A synaptic protein implicated in schizophrenia or autism? Prog Neuropsychopharmacology Biological Psychiatry 82: 187–194
Rodríguez-Palmero A, Boerrigter MM, Gómez-Andrés D et al. (2021) DLG4-related synaptopathy: a new rare brain disorder. Genet Med 23: 888–899
Kilisch M, Gere-Becker M, Wüstefeld L et al. (2023) Simple and Highly Efficient Detection of PSD95 Using a Nanobody and Its Recombinant Heavy-Chain Antibody Derivatives. Int J Mol Sci 24: 7294
Sograte-Idrissi S, Schlichterhaerle T, Duque-Afonso CJ et al. (2020) Circumvention of common labelling artefacts using secondary nanobodies. Nanoscale 12: 10226–10239
Dosemeci A, Weinberg RJ, Resse TS, Tao-Cheng JH (2016) The Postsynaptic Density: There Is More than Meets the Eye Front. Synaptic Neurosci 8: 23
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Opazo, F., Frey, S. Neue Einzeldomänen-Antikörper-basierte Reagenzien zum Nachweis von PSD-95. Biospektrum 29, 649–650 (2023). https://doi.org/10.1007/s12268-023-2037-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-023-2037-1